Highly sensitive system and method for analysis of troponin
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G01N-033/58
G01N-033/68
G01N-033/577
출원번호
US-0348120
(2016-11-10)
등록번호
US-9977031
(2018-05-22)
발명자
/ 주소
Goix, Philippe
Puskas, Robert
Todd, John
Livingston, Richard
Held, Douglas
Wu, Allan H. B.
출원인 / 주소
Singulex, Inc.
대리인 / 주소
McDonnell Boehnen Hulbert & Berghoff LLP
인용정보
피인용 횟수 :
0인용 특허 :
145
초록
The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin, Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
대표청구항▼
1. A method for determining the presence or amount of cardiac troponin selected from the group consisting of cardiac I (cTnI), cardiac troponin T (cTnT), complexes of cTnI, complexes of cTnT, and combinations thereof, in a blood, serum or plasma sample from an apparently healthy human subject, the m
1. A method for determining the presence or amount of cardiac troponin selected from the group consisting of cardiac I (cTnI), cardiac troponin T (cTnT), complexes of cTnI, complexes of cTnT, and combinations thereof, in a blood, serum or plasma sample from an apparently healthy human subject, the method comprising an assay having a sensitivity for cardiac troponin of less than 3 pg/mL and comprising: (a) contacting the cardiac troponin from the sample with a label comprising a binding partner for the cardiac troponin and a detectable moiety; and(b) counting individual digital events representing binding of the binding partner to single molecules of the cardiac troponin, wherein each individual digital event comprises a signal representing a single molecule of troponin in the sample;(c) determining a total signal as a sum of the individual digital events and relating the sum to the presence or a concentration of cardiac troponin in the sample. 2. The method of claim 1, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 10 pg/mL. 3. The method of claim 1, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 5 pg/mL. 4. The method of claim 1, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 3 pg/mL. 5. The method of claim 1, wherein the signal is a photon signal. 6. The method of claim 5, wherein the photon signal is a fluorescent signal. 7. The method of claim 1, wherein the detectable moiety comprises a fluorescent molecule. 8. The method of claim 1, wherein the cardiac troponin is cTnI. 9. The method of claim 1, wherein the cardiac troponin is cTnT. 10. The method of claim 1, wherein the cardiac troponin is cTnI and complexes of cTnI. 11. The method of claim 1, wherein the cardiac troponin is cTnT and complexes of cTnT. 12. The method of claim 1, further comprising eluting the label from the troponin prior to counting the individual digital events. 13. The method of claim 1 wherein step b comprises determining the detectable moiety in an interrogation space defined by the focus of a beam from an electromagnetic radiation source. 14. The method of claim 13 wherein the counting the digital events comprises detecting the detectable moiety in an analyzer comprising: (a) an electromagnetic radiation detector operably connected to the interrogation space for measuring an electromagnetic characteristic of the detectable moiety; and(b) a microscope objective lens situated between the interrogation space and the detector. 15. An assay for determining the presence or amount of cardiac troponin selected from the group consisting of cardiac I (cTnI), cardiac troponin T (cTnT), complexes of cTnI, complexes of cTnT, and combinations thereof, in a blood, serum or plasma sample from an apparently healthy human subject, the method comprising: i) labeling the cardiac troponin from the sample with a label comprising a binding partner for the troponin and a detectable moiety; andii) counting individual digital events representing binding of the binding partner to the cardiac troponin, wherein each individual digital event is provided as a signal representing a single molecule of cardiac troponin in the sample;iii) determining a total signal as a sum of the digital events and relating the sum to a concentration of cardiac troponin in the sample, wherein the determining the total signal and relating the sum to the concentration of troponin comprises a sensitivity for cardiac troponin in the sample of less than 3 pg/mL. 16. The assay of claim 15, wherein the sensitivity comprises a coefficient of variation of less than about 10%. 17. The assay of claim 15, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 10 pg/mL. 18. The assay of claim 15, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 5 pg/mL. 19. The assay of claim 15, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 3 pg/mL. 20. The assay of claim 15, wherein the signal is a photon signal. 21. The assay of claim 20, wherein the photon signal is a fluorescent signal. 22. The assay of claim 15, wherein the detectable moiety comprises a fluorescent molecule. 23. The assay of claim 15, wherein the cardiac troponin is cTnI. 24. The assay of claim 15, wherein the cardiac troponin is cTnT. 25. The assay of claim 15, wherein the cardiac troponin is cTnI and complexes of cTnI. 26. The assay of claim 15, wherein the cardiac troponin is cTnT and complexes of cTnT. 27. A method for determining the presence or amount of cardiac troponin selected from the group consisting of cardiac I (cTnI), cardiac troponin T (cTnT), complexes of cTnI, complexes of cTnT, and combinations thereof, in a blood, serum or plasma sample from an apparently healthy human subject, the method comprising: i) counting individual binding events representing binding of a binding partner to single molecules of cardiac troponin from the sample;ii) determining a total signal as a sum of the binding events and relating the sum to a concentration of cardiac troponin in the sample, wherein the determining the total signal and relating the sum to the concentration of troponin comprises a sensitivity for cardiac troponin in the sample of less than 3 pg/mL. 28. The method of claim 27, wherein the counting individual binding events comprises detecting a label corresponding to the single molecules of the cardiac troponin from the sample. 29. The method of claim 28, wherein the label comprises the binding partner for the cardiac troponin and a detectable moiety. 30. The method of claim 29, wherein the detectable moiety is a photon emitting moiety. 31. The method of claim 30, wherein the photon emitting moiety is a fluorescent moiety. 32. The method of claim 27, wherein the binding partner comprises an antibody or a binding portion thereof and the detectable moiety is a fluorescent moiety. 33. The method of claim 27, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 10 pg/mL. 34. The method of claim 27, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 5 pg/mL. 35. The method of claim 27, wherein the total signal relates to a concentration of cardiac troponin in a sample of less than about 3 pg/mL. 36. The method of claim 27, wherein the cardiac troponin is cTnI. 37. The method of claim 27, wherein the cardiac troponin is cTnT. 38. The method of claim 27, wherein the cardiac troponin is cTnI and complexes of cTnI. 39. The method of claim 27, wherein the cardiac troponin is cTnT and complexes of cTnT. 40. The method of claim 27, wherein the determining the total signal and relating the sum to the concentration of troponin comprises a sensitivity for cardiac troponin in the sample of less than 3 pg/mL. 41. The assay of claim 27, wherein the sensitivity comprises a coefficient of variation of less than about 10%.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (145)
Heller Michael J. (Encinitas CA) Tu Eugene (San Diego CA), Active programmable electronic devices for molecular biological analysis and diagnostics.
Chang, Richard K.; Pan, Young-Le; Pinnick, Ronald G.; Hill, Steven C., Aerosol fluorescence spectrum analyzer for rapid measurement of single airborne particles.
Crosby,Peter A.; Morris,Deborah L.; Soane,Mark M., Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin.
Baer Thomas M. (Mountain View CA) Dietz Louis J. (Mountain View CA) Dubrow Robert S. (San Carlos CA) Hayter Paul G. (Los Altos CA) Hodges Michael (Palo Alto CA) Manian Bala S. (Los Altos Hills CA) Sh, Apparatus and method for volumetric capillary cytometry.
Serena,Joaqu��n; Dāvalos,Antoni; Castellanos,Mar; Castillo,Jos��; Diamond,Cornelius Allen, Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof.
Chow Calvin Y. H. ; Parce John Wallace ; McReynolds Richard J. ; Kennedy Colin B. ; Bousse Luc J., Controller/detector interfaces for microfluidic systems.
Bergmann, Andreas; Morgenthaler, Nils; Papassotiriou, Jana; Struck, Joachim; Ng, Leong L., Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP.
Bergmann, Andreas; Morgenthaler, Nils; Papassotiriou, Jana; Struck, Joachim; Anker, Stefan, Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients.
Valkirs, Gunars E.; Dahlen, Jeffrey R.; Kirchick, Howard J.; Buechler, Kenneth F., Diagnostic markers of stroke and cerebral injury and methods of use thereof.
Hoffman Michael A. (Carmel CA), Fluorescent-particle analyzer with timing alignment for analog pulse subtraction of fluorescent pulses arising from diff.
Wada, H. Garrett; Kopf-Sill, Anne R.; Alajoki, Marja Liisa; Parce, J. Wallace; Wang, Benjamin N.; Chow, Andrea W.; Dubrow, Robert S., Focusing of microparticles in microfluidic systems.
Swedberg Sally A. (Los Altos CA) Kaltenbach Patrick (Bischweier DEX) Witt Klaus E. (Keltern DEX) Bek Fritz (Waldbronn DEX) Mittelstadt Laurie S. (Belmont CA), Fully integrated miniaturized planar liquid sample handling and analysis device.
Dollinger Gavin D. (San Francisco CA) Cunico Robert L. (Hercules CA) Kunitani Michael G. (San Rafael CA), HPLC light scattering detector for biopolymers.
Mathies Richard A. (Contra Costa County CA) Peck Konan (Contra Costa County CA) Stryer Lubert (Santa Clara County CA), High sensitivity fluorescent single particle and single molecule detection apparatus and method.
Ambrose W. Patrick ; Grace W. Kevin ; Goodwin Peter M. ; Jett James H. ; Orden Alan Van ; Keller Richard A., High throughput analysis of samples in flowing liquid.
Goix, Philippe J.; Puskas, Robert; Todd, John; Livingston, Richard A.; Held, Douglas; Wu, Alan, Highly sensitive system and method for analysis of troponin.
Goix, Philippe; Puskas, Robert; Todd, John; Livingston, Richard; Held, Douglas; Wu, Allan H. B., Highly sensitive system and method for analysis of troponin.
Goix, Philippe; Puskas, Robert; Todd, John; Livingston, Richard; Held, Douglas; Wu, Allan H. B., Highly sensitive system and method for analysis of troponin.
Goix, Philippe J.; Puskas, Robert; Todd, John; Livingston, Richard A.; Held, Douglas; Wu, Alan, Highly sensitive system and methods for analysis of troponin.
Bergmann, Andreas; Ernst, Andrea; Hampel, Harald, In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders.
Witt Klaus E. (Keltern DEX) Kaltenbach Patrick (Bischweier DEX) Bek Fritz (Waldbronn DEX) Swedberg Sally A. (Los Altos CA) Mittelstadt Laurie S. (Belmont CA), Low voltage miniaturized column analytical apparatus and method.
Begg Geoffrey Stephen (Heidelberg AUX) Simpson Richard John (Richmond AUX) Burgess Antony Wilks (Camberwell AUX), Method allowing sequential chemical reactions.
Purvis ; Jr. Norman B. (1010 Lawnview Ct. Franklin TN 37064) Giorgio Todd D. (3608 Westbrook Dr. Nashville TN 37205), Method and apparatus for determining absolute particle size, surface area and volume normalized fluorescence using forwa.
Cherukuri Satyam C. (Cranbury NJ) Demers Robert R. (Cranbury NJ) Fan Zhong H. (Middlesex NJ) Levine Aaron W. (Lawrenceville NJ) McBride Sterling E. (Lawrence Township ; Mercer County NJ) Zanzucchi Pe, Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device.
Bergmann, Andreas, Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides.
Bergmann, Andreas; Papassotiriou, Jana; Struck, Joachim; Morgenthaler, Nils; Anker, Stefan, Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease.
Seidel Claus,DEX ; Gunther Rolf,DEX ; Lupke Stefan,DEX, Method for differentiating or detecting particles in a sample by identifying signal segments of time-resolved, optical raw signals from the sample on the basis of single photon detection.
Goix, Philippe J.; Puskas, Robert; Todd, John; Livingston, Richard A.; Held, Douglas, Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties.
Bergmann, Andreas; Struck, Joachim, Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method.
Bergmann, Andreas; Struck, Joachim, Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method.
Goix, Philippe J.; Puskas, Robert; Todd, John; Livingston, Richard A.; Held, Douglas, Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry.
Robotti, Karla M.; Yin, Hongfeng, Methods and using chemico-mechanical microvalve devices for the selective separation of components from multi-component fluid samples.
Buechler,Kenneth F.; McPherson,Paul H., Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays.
Bergmann, Andreas; Struck, Joachim; Morgenthaler, Nils G., Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists.
Kaltenbach Patrick,DEX ; Swedberg Sally A. ; Witt Klaus E.,DEX ; Bek Fritz,DEX ; Mittelstadt Laurie S., Miniaturized planar columns for use in a liquid phase separation apparatus.
Kaltenbach Patrick (Bischweier DEX) Swedberg Sally A. (Los Altos CA) Witt Klaus E. (Keltern DEX) Bek Fritz (Waldbronn DEX) Mittelstadt Laurie S. (Belmont CA), Miniaturized planar columns in novel support media for liquid phase analysis.
Bottomley Paul A. (Clifton Park NY) Edelstein William A. (Schenectady NY), NMR Imaging of the transverse relaxation time using multiple spin echo sequences.
Hollis Mark A. (Concord MA) Ehrlich Daniel J. (Lexington MA) Murphy R. Allen (Boxboro MA) Kosicki Bernard B. (Acton MA) Rathman Dennis D. (Ashland MA) Chen Chang-Lee (Sudbury MA) Mathews Richard H. (, Optical and electrical methods and apparatus for molecule detection.
Goodwin Peter M. ; Jett James H. ; Keller Richard A. ; Van Orden Alan K. ; Machara Nicholas P., Single molecule identification using selected fluorescence characteristics.
Hugo Katus DE; Anneliese Borgya DE; Klaus Hallermayer DE; Siegfried Looser DE, Specific antibodies to troponin T, their production and use in a reagent for the determination of myocardial necrosis.
Galambos, Paul C.; Okandan, Murat; Montague, Stephen; Smith, James H.; Paul, Phillip H.; Krygowski, Thomas W.; Allen, James J.; Nichols, Christopher A.; Jakubczak, II, Jerome F., Surface-micromachined microfluidic devices.
Doth Margit,DEX ; Petry Christoph,DEX, Synthetic calibrators for use in immunoassays, comprising the analytes or partial sequences thereof which are conjugated to inert carrier molecules.
Myers Stephen A. (25 Nimitz Pl. Old Greenwich CT 06870), System and method for determining changes in fluorescence of stained nucleic acid in electrophoretically separated bands.
Muller Ralph,DEX ; Sauer Markus,DEX ; Zander Christoph,DEX, System for distinguishing fluorescent molecule groups by time resolved fluorescence measurement.
Zeiher, Andreas M.; Heeschen, Christopher; Dimmeler, Stefanie; Hamm, Christian, sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.